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Abstract 
We have investigated the involvement of activin receptors and TGF/I type I receptor in zebrafish development. Overexpression of 
either full-length or a truncated form of mouse ActR-IIA interferes with the development. Different splice variants of mouse ActR-IIB 
have distinct effects; ActR-IIB4 induces abnormal embryos, whereas ActR-IIB2 does not. Activin and TGFj3 type I receptors can in- 
duce axis duplications. Co-expression of ActR-IA or ActR-IB with the type II activin receptors results in a synergistic increase of the 
frequency of axis duplication. Moreover, ActR-IIB2 is synergistic with ActR-IA and ActR-IB, demonstrating that ActR-IIB2 can inter- 
act with the zebrafish ligand. Overexpression of TGFj?R-I with ActR-IIA or ActR-IIB4 results in a synergistic increase in frequency of 
abnormal embryos, whereas in combination with ActR-IIB2 no such increase occurs. 
Keywords: Zebrafish; Activin receptors; Axis formation 
1. Introduction 
The TGFP superfamily of growth factors is a diverse 
group of signaling molecules which are involved in the 
differentiation and physiological activity of a wide range 
of cell types. Members of this superfamily and their cog- 
nate receptors have been implicated to be involved in 
mesoderm induction and axes formation/ patterning in the 
vertebrate embryo. The role of activin as well as bone 
morphogenetic protein-4 (BMP4) and Vgl (a BMP re- 
lated protein) in early vertebrate development has been 
extensively studied in amphibians (Asashima et al., 1990; 
Smith et al., 1990; Thomsen et al., 1990, van den Ei- 
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jnden-van Raaij et al., 1990; Koster et al., 1991; Dale et 
al., 1992; Jones et al., 1992; Dale et al., 1993; Smith, 
1993; Schulte-Merker et al., 1994a). Activin and TGFB 
bind to receptor heterodimeric complexes composed of 
type I and type II serine/threonine kinase receptors (for 
recent reviews see Mathews, 1994; ten Dijke et al., 
1994a). The ligands initially bind their type II receptors, 
which subsequently associate with type I receptors to 
form an active signaling complex by activation of the 
serine/threonine kinase contained in the intracellular do- 
main of the receptors. This mechanism has been de- 
scribed in detail for TGFP and its receptors and postulates 
that the type I receptor requires a type II receptor to bind 
the specific ligand in order to activate the downstream 
signal transduction pathways (Wrana et al., 1994). Con- 
sequently, ligand specificity of type II receptors can be 
revealed relatively easily whereas the binding character- 
istics of a type I receptor can only be disclosed in the 
presence of the correct type II receptor. Thus far only one 
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TGF/I type II receptor gene (TGFBR-II) has been identi- 
fied (Lin et al., 1992), whereas for activin, two type II 
receptor genes are known; ActR-IIA (Mathews and Vale, 
1991) and ActR-IIB (Attisano et al., 1992), of which the 
latter encodes four different splice variants in the mouse. 
Six different type I receptor genes (nomenclature re- 
viewed by Mathews, 1994) have been cloned and their 
ligand specificities have been characterized. TGFBR-I 
(ALK-5, R4, Franz& et al., 1993; He et al., 1993) is in- 
volved in both binding and signaling of TGFB in a com- 
plex with TGF/IR-II (Franz& et al., 1993). ActR-IA, 
(TskL7, ALK-2, Rl, ActRI; Attisano et al., 1993; Ebner 
et al., 1993; He et al., 1993; ten Dijke et al., 1993) and 
ActR-IB (ALK-4, R2; ten Dijke et al., 1993; He et al., 
1993; Carcamo, 1994; ten Dijke et al., 1994b) have been 
identified as activin type I receptors, since these receptors 
bind activin in the presence of activin type II receptors. In 
addition ActR-IA is a type I receptor for osteogenic pro- 
tein-l (OP-1), whereas ALK-3 and BMPR-IB, also 
known as ALK-6, are type I receptors for BMP4 and OP- 
1 (ten Dijke et al., 1994c). 
In Xenopus it has been concluded from experiments in 
which full-length or truncated type II activin receptors 
were overexpressed that activin receptor signaling path- 
ways may be involved in vivo in the process of mesoderm 
induction and axis formation (Kondo et al., 1991; 
Mathews et al., 1992; Hemmati-Brivanlou et al., 1992; 
Hemmati-Brivanlou and Melton, 1992; Nishimatsu et al., 
1995). Such truncated activin type II receptors can bind 
ligand but lack the intracellular kinase domain which is 
involved in signal transduction and as such are supposed 
to function as dominant negative variants. 
We have systematically studied the involvement of ac- 
tivin receptors and TGF#I receptors in early embryonic 
zebrafish development and explored the zebrafish as a 
vertebrate model to determine the potential complex for- 
mation of type I and type II receptors in vivo. Activin has 
been shown to induce in vitro the expression of several 
primary response zebrafish genes which are the earliest 
markers for mesoderm induction. Upon treatment of ze- 
brafish animal caps with activin the expression of no tail, 
the zebrafish homologue of mouse BruchyuryT (Schulte- 
Merker et al., 1992, 1994b) and snail (Hammerschmidt 
and Nusslein-Volhard, 1993) are induced. Treatment of 
dissociated zebrafish blastula cells with activin results in 
increased expression of axial (Strlhle et al., 1993) and 
goosecoid (unpublished observations, I. Joore). The ex- 
pression patterns of these genes in the zebrafish embryo 
strongly suggest that the gene products are involved in 
mesoderm formation in the zebrafish embryo and that the 
expression of these genes can be regulated upon binding 
of activin to zebrafish serinelthreonine kinase receptors. 
In the present study we demonstrate that truncated and 
full-length activin and TGF/? receptors when overex- 
pressed interfere with normal zebrafish development. The 
disturbance of zebrafish development upon over- 
expression of truncated mouse ActR-IIA is specific, since 
the abnormalities thus induced are rescued upon co- 
injection of full-length ActR-IIA. Overexpression of dif- 
ferent splice variants of full-length mouse ActR-IIB re- 
sults in different effects in zebrafish embryos; ActR-IIB2 
does not interfere with normal development whereas 
A&R-IIB4 does. The zebrafish embryo was further ex- 
ploited for co-expression of different combinations of 
type I and activin type II receptors to assess the in vivo 
complex formation between activin type II receptors and 
type I receptors. From our data we conclude that these 
receptors are involved in axis formation and that the 
binding characteristics of the endogenous zebrafish li- 
gand(s) which interact with the activin receptors are dif- 
ferent from the known binding specificity of activin for 
these receptors. 
2. Results 
2.1. Overexpression offull-length and truncated type II 
uctivin receptors disturbs zebrufish development 
In order to determine the relevance of activin type II 
receptors in zebrafish development, we overexpressed 
full-length and truncated forms of these receptors in early 
zebrafish embryos and assayed the effects on embryonic 
development. Here we show that ectopic expression of 
truncated mouse ActR-IIA which lacks the complete in- 
tracellular kinase domain (see Section 4 for details on 
construct) interferes with the normal development of ze- 
brafish embryos. RNA encoding the truncated receptor 
was injected at the interphase between yolk and cyto- 
plasm of l-cell to 4-cell stage zebrafish embryos. To as- 
sess correct expression, the receptor sequences were epi- 
tope-tagged (Field et al., 1988) and whole mount receptor 
immunostaining was performed. The exogenous receptors 
were expressed correctly in the cell membrane and could 
be distributed evenly throughout the embryo as shown in 
Fig. 1C. However, most often the expression pattern was 
somewhat mosaic (Fig. 1 A,B) which is in agreement with 
the expression patterns observed upon RNA injections in 
Xenopus embryos (Amaya et al., 1993). Probably, the 
variable expression is due to the slow diffusion of the 
RNA from the injection site and the rapid partitioning of 
the cytoplasm during cleavage. The extent of mosaic ex- 
pression in the zebrafish embryos was similar for injec- 
tions performed at the l-cell up to the 4-cell stage inde- 
pendently of whether RNA was introduced in the yolk- 
cytoplasm interface or in the cytoplasm directly. 
During the gastrulation no gross morphological differ- 
ences were observed between uninjected and control in- 
jected embryos and epiboly proceeded at normal rate. 
However, when we analyzed the embryos 30 h post fer- 
tilization, the injected embryos were clearly affected in 
comparison to uninjected or control injected embryos 
(Fig. 1D). We have chosen to analyze embryos at 30 h 
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Fig. I. Overexpression of truncated ActR-IIA or full-length ActR-IIA disturbs normal zebrafish development. Zebratish embryos were injected at the 
l-cell to 4-cell stage with water (D), or with in vitro capped RNA encoding either truncated ActR-IIA (A-C and E-H) or wild-type A&-IIA (I-J). 
Injected embryos were tixed at 50-6046 epiboly and processed to immunohistochemistry (see Section 4) with the anti-tag antibody (12CAS) to show 
correct expression of the injected RNA. After incubation with the secondary fluorescently labeled antibody, the embryos were analyzed by confocal 
laser scanning microscopy. Mosaic expression of truncated A&-IIA (A,B). Homogenous expression of truncated ActR-IIA (C). Embryos were in- 
jected as mentioned above and subsequently allowed to develop and analyzed at 30 h of development. Control, water-injected embryos, developed 
normally (D). Embryo displaying mild abnormalities with the eyes almost fused and the anterior head structures reduced (E). Embryo lacking all head 
structures (F). Embryo characterized by a severely truncated tail (G). Most severely affected embryo, no head or tail structures. Note the presence of 
some square somites and notochord (arrows) (H). Completely ventrahzed embryo due to overexpression of full-length ActR-IIA (I). Detail of the otic 
vesicle of wild type embryo (Jl) and defects observed upon overexpression of full-length ActR-IIA; duplication of the otic vesicle (J2,3). For (A) and 
(C), a lateral view, animal pole up; in (B) lateral view, animal pole to the left top; in (D-I) a lateral view with anterior to the left. In (J) only the otic 
vesicle is shown in a lateral view. 
post fertilization since by that time a complete body plan 
has been established, tail straightening has been com- 
pleted and blood flow through the vascular system takes 
place. Overexpression of truncated ActR-IIA caused a 
range of distinct malformations (see Table 1). Either the 
anterior structures were affected slightly, e.g. one or both 
eyes were missing, the eyes were fused, the telencephalon 
was truncated (Fig. 1E) or, at a tenfold lower frequency, 
all the anterior structures including rhombomere 5 and the 
otic vesicle were missing (Fig. 1F). Minor posterior de- 
fects such as a bent tail or partial truncation of the tail 
were observed at a threefold higher frequency than in the 
control injected embryos. In 6% of the embryos, a com- 
plete truncation of the tail was observed (Fig. 1G) and in 
22% of the injected embryos, both anterior and posterior 
structures were missing (Fig. IH). Even in the most se- 
verely affected embryos, there were always dorsal meso- 
dermal structures as (square) somites or short stretches of 
notochord (Fig. 1H). 
Overexpression of full-length ActR-HA results in a 
different pattern of abnormalities compared to those ob- 
served upon injection of RNA encoding truncated ActR- 
IIA. The most severe phenotype was rarely observed. 
Typically, embryos injected with RNA encoding full- 
length ActR-IIA displayed malformations of the early ear 
structures at a high frequency of 44%. Interestingly, such 
abnormalities never occurred upon overexpression of 
truncated ActR-IIA. Either the presence of only one in- 
stead of two otoliths per otic vesicle was observed or 
multiplication of the otic vesicle and/or the otoliths (Fig. 
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Table 1
Axial defects in embryos injected with truncated or full-length Act IIA 
Control Truncated ActR- IIA 
ActR- IIA 
No. of embryos injected 56 183 106 
Normal embryos (Fig. 1D) (%) 96 28 58 
Mild anterior defects (Fig. 1E) (96) 0 28a 27b 
Anterior structures including otic 0 2 4 
vesicle missing (Fig. 1F) (%) 
Minor posterior defects (%) 4 14 5 
No tail, tail severely truncated 0 6 1 
(Fig. 1G) (%) 
Severely affected anterior and 0 22 5 
posterior (Fig. 1H) (%) 
One nanogram of RNA encoding either truncated or full-length ActR- 
IIA was injected at the l-4 cell stage (see Section 4) and the embryos 
were analyzed at 30 h post fertilization. 
aNo defects in otic vesicles. 
b19 out of 29 embryos with defects in otic vesicle. 
Injection of increasing concentrations of RNA encod- 
ing truncated A&-IIA results in an increasing frequency 
of abnormal embryos reaching 100% (Fig. 2A). Injection 
1 J). Furthermore, completely ventralized embryos were 
observed without any anterior structures, consisting of an 
enlarged pericardium with a truncated but beating heart 
and a short tail with square somites (Fig. 11). In contrast 
to what has been observed upon overexpression of full- 
length ActR-IIA in Xenopus embryos, secondary axes 
were not induced. 
of increasing doses of RNA encoding full-length ActR- 
IIA resulted in increasing percentages of abnormal devel- 
Subsequently, we investigated the effects of overex- 
opment of zebrafish embryos, although 45% was the 
highest percentage that could be achieved (Fig. 2A). To 
pression of ActR-IIB; four different splice variants have 
establish specificity of the effects observed upon overex- 
pression of truncated ActR-IIA, we performed a rescue 
been described in the mouse. These splice variants exhibit 
experiment with full-length ActR-IIA. To rescue the ef- 
fect of the truncated receptor, a constant amount of RNA 
encoding truncated ActR-IIA was co-injected with in- 
creasing doses of full-length ActR-IIA RNA which at a 
concentration of 600 r&l results in a complete rescue 
(Fig. 2B). At concentrations of full-length ActR-IIA RNA 
of 600 ng/pl and higher, abnormal ear structures were 
observed at high frequency which is, as previously de- 
scribed, an abnormality specific for full-length ActR-IIA 
phenotype. These data show that the effects of overex- 
pressed truncated ActR-IIA on zebrafish development can 
be rescued by co-expression of the full-length receptor, 
indicating that the observed malformations are not due to 
physical disruption of the embryos or toxicity of the 
RNA, but to specific interference of the overexpressed 
receptor (variants) with endogenous ignaling pathways. 
Only at an intricately balanced co-expression of truncated 
and full-length A&-IIA does normal development take 
place since both the impaired function as well as en- 
hanced activity of this receptor seem to affect zebrafish 
development. 
0 300 600 900 1200 
Concentration RNA [ngbl] 
-+ 
0 300 600 900 1200 
Concentration Act&IIA RNA [ngbl] 
Fig. 2. Dose dependent induction of abnormal embryonic phenotypes upon overexpression of truncated and wild-type ActR-IIA and rescue of the 
truncated ActR-IIA phenotype by full-length ActR-IIA. (A) The frequency of defects at 30 h of development upon injection of increasing concentra- 
tions of RNA encoding truncated ActR-IIA (open squares) or wild-type ActR-IIA (closed squares). (B) Rescue of defects induced due to injection of a 
constant amount of RNA encoding truncated ActR-IIA (600 ng/@) by co-injection of increasing concentrations of RNA encoding wild-type ActR-IIA, 
expressed as the frequency of abnormal embryos. The line is composed of two different symbols, with open squares for phenotypes induced by trun- 
cated ActR-IIA and closed squares when malformations specific for full-length ActR-IIA, like aberrant otic vesicles, are observed at high frequency. 
For each point, at least 30 embryos were injected and analyzed. 
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different affinities for activin ranging from high for ActR- 
IIB 1 and -2 (K,, 100 PM) to low for A&-IIB3 and -4 
(Kd 380 PM) (Attisano et al., 1992). In zebrafish embryos, 
we overexpressed the two variants which are identical in 
their intracellular domain and both lack the exon encod- 
ing 24 amino acids intracellularly but differ in their extra- 
cellular domains; ActRII-B2 contains 8 amino acids 
which lack in the extracellular domain of ActR-IIB4. At 
the carboxy terminus, the cDNAs were extended with the 
epitope which is recognized by the monoclonal antibody 
KT3 (MacArthur and Walter, 1984) such that correct ex- 
pression could be assayed upon RNA injection identical 
to the data obtained for ActR-IIA both for ActR-IIB2 and 
ActR-IIB4 (data not shown; see Fig 1A-C). Overexpres- 
sion of both full-length and truncated ActR-IIB2 in ze- 
brafish embryos did not affect development, even though 
RNA was injected at very high concentrations (up to 
3600 nglpl). In contrast, both the full-length and the trun- 
cated form of the shorter splice variant ActR-IIB4 inter- 
fered very efficiently with signaling of endogenous recep- 
tors resulting in a high frequency of abnormal embryos. 
The abnormalities observed were very similar to those 
described for overexpression of full-length and truncated 
ActR-IIA, respectively; again no ectopic axes were ob- 
served. 
2.2. Overexpression of type I serinelthreonine kinase 
receptors 
A&R-IA and ActR-IB have been shown to interact 
with type II activin receptors in binding of activin and 
subsequent signal transduction (Ebner et al., 1993; Car- 
camo et al., 1994). Overexpression of either full-length 
mouse ActR-IA or full-length mouse ActR-IB in ze- 
brafish embryos results in axis duplication (Fig. 3A-D). 
Axis bifurcation was observed to different extents and 
always started from the trunk or just anterior to the tail 
and was propagated anteriorward, resulting in bifurcated 
embryos with one common tail. 
TGFBR-I has been identified as a TGF/I type I recep- 
tor, which binds TGFB upon co-expression with the type 
II TGF/3 receptor and mediates the TGFB signal (Franz&t 
et al., 1993; Bassing et al., 1994; Wrana et al., 1994). 
Overexpression of the human TGFB type I receptor dis- 
turbs normal zebrafish development. In analogy to the 
effects observed for ActR-IA and ActR-IB, TGF/IR-I can 
also induce axis duplication (data not shown; see Table 
2). These data indicate that the human TGFB type I recep- 
tor can interact with an endogenous zebrafish ligand as 
well as with a zebrafish type II receptor. 
2.3. Co-injection of RNAs encoding type I and type II 
receptors 
At present not all ligands for the serine/threonine 
kinase receptors have been identified or are not available 
in sufficient quantities to perform binding and cross- 
linking studies in order to determine the potential com- 
plex formation between type II activin receptors and 
known type I receptors. Therefore, we co-expressed these 
receptors in zebrafish embryos to assess for the synergis- 
Table 2 
Co-injection of type II activin receptors and type I receptors: frequency 
of severely affected embryos upon overexpression of type I and type II 







ActR-IA (50) 33 33 
ActR-IB (100) 45 18 
TGFBR-I (600) 127 13 
ActR-IIA (900) 25 8 
ActR-IIB2 (600) 72 0 
ActR-IIB4 (300) 58 19 





embryos (%)b x-foldc 
B 
ActR-IA + ActR-IIA 64 65 41 I.6 
ActR-IA + ActR-IIBZ 82 64 33 2.0 
ActR-IA + ActR-IIB4 66 89 52 1.7 
C 
ActR-IB + ActR-IIA 99 42 26 1.6 
ActR-IB + ActR-IIB2 52 40 18 2.2 
ActR-IB + ActR-IIB4 37 62 37 1.7 
D 
TGF@R-I + ActR-IIA 42 60 21 2.9 
TGFBR-I + ActR-IIB2 97 10 13 0.8 
TGFj3R-I + ActR-IIB4 40 58 32 1.8 
(A) Different concentrations of RNA encoding the different receptors 
were chosen such that at most 1 out of 3 embryos was severely af- 
fected. Only embryos severely affected were taken into account (see 
Section 2). An embryo is considered severely affected when either 
complete anterior or posterior structures are missing, or when axis 
duplications are present. Embryos in which, e.g. only a duplication of 
the otic vesicle was observed were not considered as severe, which 
explains the discrepancy of 8% abnormal embryos due to injection of 
900 ng&I RNA encoding ActR-IIA as given in this table. whereas in 
the graph of Fig. 2A a total percentage of 52% abnormal embryos is 
given. (B) Overexpression of ActR-IA in combination with the different 
type II activin receptors. (C) Overexpression of ActR-IB in combina- 
tion with the different type II activin receptors. (D) Overexpression of 
TGFBR-I in combination with typ II activin receptors. The results of a 
typical experiment are given. 
an, number of embryos injected. 
bFrequency of abnormal embryos as expected from the data given in A. 
bRelative comparison of actual frequency of abnormal embryos upon 
co-expression of type I and type II receptors and frequency as calcu- 
lated from the data in Table 2A. A relative comparison which results in 
a larger number than I, indicates that the co-expressed receptors result 
in a synergistic effect. 
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tic disturbance of normal development as an indication of 
signaling complex formation. RNAs encoding type I 
and/or type II receptors were co-injected in zebrafish zy- 
gotes to determine which combination of type I and type 
II receptors would result in the formation of an active 
signaling receptor complex in this system. The concen- 
tration of RNA for a single receptor was chosen such that 
at most one out of three injected embryos was severely 
affected (Table 2). This was done in order to score the 
maximum increase in phenotypes occurring as a conse- 
quence of co-injection of both receptors type I and II. In 
these experiments only the frequency of severely affected 
embryos was determined. An embryo is defined as se- 
verely affected when dramatic effects on either antero- 
posterior patterning were observed such as the absence of 
the tail, the head or both head and tail or when axis dupli- 
cations were observed (Fig. 3). When multiple axes are 
formed the phenotype is very complex and difficult to 
assess as is shown in Fig. 3E,F. Therefore we did not 
score the frequency of embryos with axis duplications 
separately. In Table 2B-D the frequency of abnormal 
embryos measured upon co-injection of type I and type II 
receptors is given in the third column. Furthermore, the 
percentage of affected embryos obtained by adding up the 
percentages brought about by each of the receptors alone 
(Table 2A) is depicted as well as the comparison between 
the actual and calculated percentages. From the data pre- 
sented in Table 2B and C we conclude that both ActR-IA 
and ActR-IB form active heteromeric complexes with all 
three type II receptors tested, because co-injection of the 
receptors results in a 1.6-2.2-fold higher incidence of 
severe phenotypes than expected from the addition of 
percentages determined upon separate injection of the 
receptors (Table 2A). Clearly, ActR-IIB2 which alone did 
not affect development can form active complexes with 
ActR-IA and ActR-IB resulting in a synergistic effect on 
development. This indicates that ActR-IIB2 may interact 
with an endogenous zebrafish ligand but does not form 
ternary complexes with endogenous type I receptors since 
even high concentrations of injected ActR-IIB2 mRNA 
do not affect zebrafish development. We thus conclude 
that ActR-IIB2 can interact with a zebrafish ligand which 
again shows that the effect of overexpressed receptors is 
not due to absorbance of endogenous growth factor, but 
rather due to the specific active complex formation with 
endogenous receptors. 
Co-injection experiments of TGFBR-I with ActR-IIA 
or ActR-IIB4, similarly cause a synergistic effect on ze- 
brafish development (Table 2D). However, co-injection 
of TGFBR-I and ActR-IIB2 does not result in an in- 
creased effect, from which we conclude that ActR-IIB2 
does not form complexes with TGFBR-I. Importantly, 
these data indicate that no ligand-independent complex 
formation and subsequent signaling takes place as a con- 
sequence of high expression levels of the overexpressed 
receptors. 
2.4. Expression pattern of primary response genes 
goosecoid and no tail and of early mesodermal marker 
axial upon injection of type I receptors alone or with type 
II receptors. 
Defects in embryos injected with RNAs encoding the 
different receptors were determined at 28-30 h after fer- 
tilization. To further investigate whether the injection of 
type I receptors alone or in combination with type II re- 
ceptors affects axis formation, the expression pattern of 
several mesodermal markers, no tail, goosecoid and axial 
(Schulte-Merker et al., 1992; Stachel et al., 1993; Strahle 
et al., 1993) was analyzed during gastrulation. In agree- 
ment to what was found for the abnormal embryos shown 
in Fig. 3 the expression pattern of these markers is very 
pleiotropic in injected embryos. At 80% epiboly, the ex- 
pression of goosecoid is restricted to the anterior shield, 
as is shown in Fig. 4Al in which in situ hybridization 
with a goosecoid probe was performed on an uninjected 
embryo. At this stage no tail is expressed in cells in the 
germ ring and in the presumptive notochord (Fig. 4Bl), 
whereas axial is expressed in a band of cells at the dorsal 
side of the embryo from the blastoderm margin to the 
Fig. 3. Overexpression of type I receptors alone or in combination with type II receptors results in axis duplication as assessed at 30 h of development. 
(A) Embryo with one complete and one additional partial axis induced upon ectopic expression of ActR-IB, lateral view, anterior to the right. (B) 
Embryo injected with ActR-IB and ActR-IIA with two almost complete axes in which the most anterior regions appear to be fused. (C) Embryo with 
two incomplete axes and a common truncated tail, injected with ActR-IB and ActR-IIB2, anterior to the left. (D) Dorsal view of axis bifurcation ante- 
rior to the tail, due to co-injection of ActR-IB and ActR-IIB2. (E.F) Embryos with multiple axes due to ectopic expression of ActR-IA and ActR-IIB4, 
dorsal view. 
Fig. 4. Whole mount in situ hybridization at 80-9096 epiboly of wild-type and injected embryos with (A) goosecoid, (B) no tail and (C) axial probes. 
(Al) Wild type goosecoid expression, (Bl) wild type no tail expression and (Cl) wild type axial expression. Examples of embryos with a clear second 
axis; (A2) goosecoid in embryos co-injected with ActR-IB and ActR-IIB2 (the two spots of expression are indicated with arrows), (B2) no tail expres- 
sion in embryos co-injected with A&-IA and ActRIIB4 and (C2) axial expression upon injection of ActR-IB (of the second axis only the broader 
base is visible at the arrow). Two broader bands of expression much wider than normal are shown in (A3) for goosecoid upon overexpression of ActR- 
IB and ActRIIB4, (B3) for no tail in ActR-IB and ActR-IIA injected embryos and (C3) for axial in embryos overexpressing ActR-IA and ActR-IIA. 
An expression of the markers which is wider than normal or with staining additional to the normal pattern is shown in (A4) for goosecoid upon 
TGF/IR-I injection, (B4) for no tail upon overexpression of ActR-IB and (C4) for axial in embryos injected with ActR-IB and ActR-IIB4. Similar 
expression patterns were observed for each of the injections of type I receptors alone or in combination with the type II receptors and the results given 
in this figure should be considered as representative examples of expression patterns rather than as typical examples due to injection of the different 
RNAs (see Section 2). 




Fig. 5. Expression of goosecoid and no tail as determined by RNase protection analysis in injected embryos. Total RNA was isolated at W-908 epi- 
holy of uninjected embryos (lane 3) embryos injected with A&-IA (lane 4). ActR-IB (lane S), TGF/IR-I (lane 6) ActR-IIA (lane 7). ActR-IIB2 (lane 
8), ActR-IIB4 (lane 9) A&-IA and -1IA (lane lo), AM-IA and -1IB2 (lane 1 l), A&-IA and -1IB4 (lane 12). ActR-IB and -1IA (lane 13). ActR-IB 
and -1IB2 (lane 14), ActR-IB and -1IB4 (lane 15), TGFBR-I and ActR-IIA (lane 16), TGF/?R-I and ActR-IIB2 (lane 17) and TGFBR-I and ActR-IIB4 
(lane 18) and hybridized to goose&d and no tail anti-sense probes (lane 1) and subjected to RNase treatment. The RNase resistant fragments were run 
on a sequencing gel and visualized by autoradiography. In lane 2 the control with tRNA which does not protect the probes against RNase digestion is 
shown. The positions of the probes and the protected fragments for goosecoid and no tail are indicated. A typical experiment is shown, the concentra- 
tions of the injected RNAs were as depicted in Table 2 
animal pole. This band is slightly broader at the margin 
and narrows down towards the animal pole (Fig. 4Cl). 
Several examples of the expression patterns of these 
Table 3 
Phospholmager data of RNase protection analysis on goosecoid and no 
tail expression 
gSC ntl gschltl 
Uninjected 53 27 2.0 
A&R-IA 52 20 2.6 
ActR-IB 123 41 3.0 
TGFBR-I 50 21 2.4 
ActR-IIA 74 31 2.4 
ActR-IIB2 91 47 1.9 
ActR-IIB4 90 53 1.7 
A&-IA + ActR-IIA 57 34 1.7 
ActR-IA + ActR-IIB2 68 37 1.8 
ActR-IA + ActR-IIB4 80 28 2.9 
ActR-IB + ActR-IIA 233 33 7.1 
ActR-IB + ActR-IIB2 179 38 4.7 
ActR-IB + ActR-IIB4 220 28 7.9 
TGFBR-I + ActR-IIA 124 40 3.1 
TGFBR-I + ActR-IIB2 110 42 2.6 
TGFBR-I + ActR-IIB4 95 35 2.7 
Quantitative analysis of the RNase protection analysis data of Fig. 5 
(see legend of Fig. 5 for details on the experimental procedure). The 
relative intensities of the radioactive bands was determined by Phos- 
pholmager analysis and expressed in arbitrary units. In the last column 
the ratio of the intensity of gmsecoid expression and the no tail ex- 
pression in the same sample was calculated. gsc, goosemid; ntl, no tail; 
gschtl, relative expression of goosecoid over no tail as calculated from 
the data upon analysis of the RNase protection data by PhosphoImager. 
markers due to overexpression of full-length receptors 
are shown in Fig. 4. Examples in which two separate 
axes are identified upon in situ hybridization are shown 
in Fig. 4A2 for goosecoid, Fig. 4B2 for no tail and in 
Fig. 4C2 for axial. In Figs. 4A3, B3 and C3 two or more 
major bands of expression are visualized with the differ- 
ent probes. Overexpression of type I receptors with or 
without type II activin receptors could also result in 
a broader band of expression than normal at this stage 
of development (shown for goosecoid in Fig. 4A4 and 
no tail in Fig. 4B4) or in a more or less normal band 
of marker expression and additional expression in 
randomly distributed cells as is shown for axial in Fig. 
4c4. 
Subsequently, we assayed the expression levels of 
goosecoid and no tail by RNase protection analysis. After 
injection, 10 embryos were randomly chosen and fixed at 
W-90% epiboly for RNA isolation. The RNAs were hy- 
bridized to goosecoid and no tail probes and subjected to 
RNase treatment. The protected fragments were run on a 
gel and visualized by autoradiography (Fig. 5). The in- 
tensities of the bands were determined with the Phospho- 
Imager and the data are expressed in arbitrary units and 
summarized in Table 3. From the ratio of goosecoid over 
no tazl expression, it becomes clear that the xpression of 
goosecoid is significantly increased upon overexpression 
of A&-IB with each of the activin type II receptors 
(Table 3). This specific induction of goosecoid expression 
due to overexpression of these receptors in comparison to 
the expression of goosecoid in embryos injected with 
other receptor combinations suggests that activation of 
goosecoid and no tail requires the activation of specific 
signal transduction pathways. 
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3. Discussion 
In this study we show that overexpression of both full- 
length and truncated activin type II receptors as well as 
full-length type I serine/threonine kinase receptors can 
interfere with normal zebrafish development. Further- 
more, we exploited the zebrafish as an in vivo model 
system to assay differences in functional characteristics of 
splice variants of ActR-IIB and the potential complex 
formation between type I and type II receptors. 
To validate our procedure for zebrafish embryo injec- 
tions, we first showed that injection in the cytoplasm at 
the l-cell stage results in similar expression patterns as 
assessed by whole mount antibody labeling, as injection 
at the interphase of yolk and cytoplasm at the l-cell to 4- 
cell stage. The receptors are expressed correctly at the cell 
membrane but the expression pattern is mosaic. Overex- 
pression of truncated ActR-IIA results in a severe distur- 
bance of the antero-posterior axis, whereas the mesoderm 
induction is not inhibited completely as even the most 
severely affected embryos exhibit some mesodermal 
structures. Although some degree of consistency in ab- 
normalities can be discerned, as we grouped them in sev- 
eral categories, the issue of reproducibility of abnormali- 
ties obtained is complicated by mosaicism. It could also 
be speculated that the promiscuity of the introduced re- 
ceptors leads to their involvement in distinct signaling 
pathways. The effects due to overexpression of truncated 
ActR-IIA are completely rescued by wild-type ActR-IIA 
which shows that the effects observed are specific. 
In the present study we show that the two splice vari- 
ants of mouse ActR-IIB have distinct effects on zebrafish 
development; the shortest variant, ActR-IIB4, induces 
abnormal embryos, whereas ActR-IIB2 is expressed cor- 
rectly but does not affect zebrafish development. From 
binding experiments in which these receptors are ex- 
pressed in COS cells, it is known that the affinity of ac- 
tivin is 3.8-fold higher for ActR-IIB2 than for ActR-IIB4 
(Attisano et al., 1992). To explain our data we initially 
speculated that the endogenous zebrafish ligand is an ac- 
tivin-like ligand with different binding characteristics 
such that it can only bind ActR-IIB4 with high affinity. 
However, upon co-injection of ActR-IIB2 with either 
ActR-IA or ActR-IB, a synergistic effect is observed, 
indicating that an endogenous ligand has the capacity to 
bind ActR-IIB2, but rather that no ternary complexes are 
formed between ActR-IIB2 and endogenous type I recep- 
tors. This possibility is further supported by the data ob- 
tained from the co-injection of ActR-IIB2 and TGF/?R-I, 
which does not show a synergistic effect, indicating that 
the co-expression of these receptors does not result in the 
formation of a functional complex. We conclude that the 
eight variable amino acids in the extracellular region of 
ActR-IIB splice variants are probably involved in the 
specificity of complex formation of this type II receptor 
with type I receptors. 
Overexpression of either full-length ActR-IIA or 
ActR-IIB in zebrafish embryos does not result in the in- 
duction of secondary body axes, which is in contrast to 
the data obtained in Xenopus where axis duplication due 
to overexpression of full-length ActR-IIA or ActR-IIB 
was observed (Kondo et al., 1991; Hemmati-Brivanlou et 
al., 1992). This discrepancy could be explained by differ- 
ences in type I receptor expression patterns in the differ- 
ent organisms. An alternative explanation could be that 
the putative mesoderm inducing signal is uniformly dis- 
tributed throughout the zebrafish blastoderm as is the case 
for the zebrafish homologue of Xenopus Vg-I (Helde and 
Grunwald, 1993) and that mosaic expression of truncated 
ActR-IIA will always allow a region of the embryo to be 
free of truncated protein and therefore with availability of 
type I receptor to signal and induce dorsal axial struc- 
tures. 
The fact that overexpression of type I activin and 
TGFP receptors interferes with normal development could 
reveal the mechanism by which these overexpressed re- 
ceptors disturb normal signaling of the endogenous recep- 
tors. For activin and TGFP type I receptors, it has been 
shown that the ligand cannot bind unless a type II recep- 
tor is present which would indicate that it is not merely 
absorbance of the ligand by the overexpressed receptors, 
but rather ternary complex formation with endogenous 
ligand(s) and receptor(s) and the consequent signal trans- 
duction which results in abnormal development. How- 
ever, recent binding studies in tissue culture cells revealed 
that BMPs can bind type I receptors with high affinity in 
the absence of type II receptors (Koenig et al., 1994; 
Penton et al., 1994; Graff et al., 1994). These data do not 
support the above proposed mechanism of action of over- 
expressed receptors, although it is unclear how such in 
vitro data exactly extrapolate to the in vivo situation. Our 
proposed explanation is in accordance with the data re- 
cently obtained from Drosophila mutant analysis in 
which there is an absolute requirement for both the type II 
and type I receptors, punt and thick venes, in order for 
dpp signaling to take place (Letsou et al., 1995; Ruberte 
et al., 1995). 
The TGFB type I receptor (Franzen et al., 1993) was 
not expected to affect zebrafish development, since TGFP 
does not induce mesoderm in the Xenopus animal cap 
assay. However, upon ectopic expression of the TGF/?R- 
II, Xenopus blastula cells become responsive to added 
TGFP indicating that the cells express an endogenous 
type I receptor which can bind TGFP and mediate its sig- 
nal (Bhushan et al., 1994). Probably, the TGF/?R-I does 
not only bind and signal in response to TGFB, but also 
has a broader ligand specificity. Such cross-reactivity of 
type I receptors has been shown for other type I receptors; 
ALK-3 and ALK-6, upon co-expression with the C. ele- 
guns type II receptor Daf-4, were identified as type I re- 
ceptors for both BMP4 and OP- 1. Furthermore, ActR-IA 
showed cross-reactivity with OP- 1 in the presence of Daf- 
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4 (ten Dijke et al., 1994~). Recently, it has been shown 
that the Xenopus homologue of ALK-3 binds both BMP-2 
and BMP4 and that this receptor is involved in the in- 
duction of ventral mesoderm in the frog embryo (Graff et 
al., 1994). 
The interpretation of the experiments in which type I 
and type II receptors were co-injected was made care- 
fully. We considered the possibility that the synergistic 
effects could have been brought about by the simultane- 
ous induction of two different pathways, which eventually 
could result in an enhanced effect. However, this does not 
explain the effects observed upon co-injection of ActR- 
IIB2 with A&-IA or -IB, because ActR-IIB2 alone does 
not interfere with an endogenous signal transduction 
pathway. Furthermore, one can also imagine that the ex- 
pression levels of the receptors in the cell membrane are 
so high that ligand independent complexes are formed. 
However, we show that the combined injection of 
TGFBR-I and ActR-IIB2 is not synergistic, indicating that 
the complexes formed are most likely ligand dependent. 
We conclude from our data that upon co-injection of type 
I and type II receptors, these overexpressed receptors do 
not depend on the presence of endogenous receptors, but 
only require an endogenous ligand to form an actively 
signaling complex. Most importantly, the induction of 
secondary axes coincides with the ectopic expression of 
several mesodermal markers, i.e. goosecoid, no tail and 
axial. 
To quantify the induction of expression of goosecoid 
and no tail we performed an RNase protection analysis. 
For no tail we did not observe a significant induction of 
expression upon injection with the different receptors, 
which was to be expected; in the in situ hybridizations 
a clear ectopic expression was observed which was on 
average never more than twice the amount of normal 
expression. Taking into account that the frequency of 
abnormal embryos was always less than 100% (see Table 
2) at most a twofold induction is to be expected, which 
is at the limit of detection in this experiment. The relative 
expression level of goosecoid over no tail as expressed 
in the last column of Table 3 indicates that the expression 
of goosecoid is 3-5-fold increased upon injection of em- 
bryos with ActR-IB in combination with each of the 
activin type II receptors, compared to the uninjected 
embryos, or embryos injected with other combinations 
of receptors. These results suggest that specific signaling 
pathways are activated by different combinations of 
receptors, resulting in subtle differences in the induction 
of mesodermal marker genes. Specificity of ActR-IB with 
respect to its down stream signaling will be studied 
in more detail in relation to an activin responsive ele- 
ment identified in the zebrafish goosecoid promoter 
(Joore et al., unpublished data). The exact signaling 
pathways activated by serineithreonine kinase receptors 
are so far unknown and will be the subject of future stud- 
ies. 
It is very tempting to speculate what the endogenous 
ligand(s) may be. The ligand(s) will belong to the TGF/3 
superfamily and activin, Vgl and BMP4 may be consid- 
ered candidates. Recently, it has been demonstrated that 
truncated type II activin receptors abolish signaling of 
both Vgl and activin in Xenopus animal caps (Schulte- 
Merker et al., 1994a). This lack of specificity of the ac- 
tivin receptors indicates that Vgl as well as other mem- 
bers of the TGF/l superfamily.are perhaps just as likely as 
activin to bind these receptors and thus to be involved in 
mesoderm induction in amphibians as has been postulated 
before (Thomsen and Melton, 1993; Dale et al., 1993) 
and more recently (Kessler and Melton, 1994, 1995). 
Moreover, Schulte-Merker et al., (1994b) have shown 
that overexpression of follistatin, an activin binding pro- 
tein which blocks activin activity (Nakamura et al., 1990; 
Asashima et al., 1991) does not interfere with the signal- 
ing of ectopically expressed Vgl in animal cap explants. 
Even though overexpression of follistatin induces neurali- 
zation of Xenopus animal caps, follistatin does not inter- 
fere with normal development of the Xenopus embryo, 
indicating that activin indeed may not be the endogenous 
mesoderm inducing factor (Schulte-Merker et al., 1994a; 
Kessler and Melton, 1994). Recently it has been shown 
that activin knock-out mice which lack both activin 
chains are not viable but develop normal mesoderm and 
form a complete, normal antero-posterior axis, excluding 
a major role for activin in these early processes (Matzuk 
et al., 1995). The data obtained with dominant negative 
variants of activin which interfere with mesoderm induc- 
tion in medaka (Wittbrodt and Rosa, 1994) seem to con- 
trast with the studies summarized above. However, it may 
be that the overexpressed dominant negative activin 
chains can form inactive dimeric ligands with other mem- 
bers of the TGF/? superfamily of growth factors and thus 
exert their effect on mesoderm induction. 
Our study provides evidence that several type I and 
type II receptors which are members of the serine/ 
threonine kinase receptor family are involved in early 
zebrafish development. However, the ligand(s) which 
interact in vivo with these receptors need to be identified. 
In the near future, zebrafish mutant analysis will probably 
shed new light on the role of the serine/ threonine kinase 
receptors and their specific ligands in early vertebrate 
development. 
4. Experimental procedures 
4.1. Plasmid constructs and in vitro transcription 
All constructs used for SP6 RNA polymerase- 
dependent in vitro transcription contained the coding se- 
quences in between the NcoI and Sal1 site of a modified 
pSP64T vector containing 5’ and 3’ untranslated regions 
of the Xenopus b-globin gene under control of the SP6 
RNA polymerase promoter (Krieg and Melton, 1984). 
C. J.M. de Pies et (11. /Mechanisms of Development 54 (1996) 225-236 235 
The construct for mouse ActR-IIA contained a Kozak 
sequence 5’ of the start codon creating an NcoI site 
(GCCACCATGG) and an HA-epitope (Field et al., 1988) 
was inserted by PCR upstream from the stop codon fol- 
lowed by a Sal1 site. Truncated mouse ActR-IIA encodes 
the extracellular domain, the transmembrane domain, but 
only 8 intracellular amino acids, followed by the HA 
epitope, a stop codon and a Sal1 site. Full-length mouse 
ActR-IIB2 and ActR-IIB4 were carboxy terminally 
tagged with the KT3 epitope (MacArthur and Walter, 
1984) and their truncated forms encode the complete ex- 
tracellular and transmembrane domains and only four 
intracellular amino acids, followed by the KT3 tag. The 
mouse ActR-IA cDNA (Ebner et al., 1993) was extended 
with the HA epitope. The mouse ActR-IB cDNA 
(Verschueren et al., 1995) and the human TGFBR-I 
cDNA (Franz&n et al., 1993) were inserted in the vector 
without untranslated regions. For RNA transcription, the 
constructs were linearized to include the 3’ Xenopus /?- 
globin sequences. The RNAs were capped during in vitro 
synthesis. 
4.2. Fish stocks and embryo injection 
Zebrafish were maintained and raised as described 
(Westerfield, 1993) and embryos were obtained by natu- 
ral matings. One-cell to 4-cell embryos, in their chorion, 
were mounted in agarose slots and injected with needles 
of ca. 5 ym width using a Narashige injection apparatus. 
A volume of ca. 1 nl, which was calibrated for each nee- 
dle, with different concentrations of RNA (O-3600 ng@l) 
was injected at the interphase between yolk and cyto- 
plasm and embryos were grown at 28S”C in l/10 the 
Hank’s solution (Westerfield, 1993). Embryos were either 
fixed for immunohistochemistry or in situ hybridization at 
50-70% and 80-90% epiboly, respectively. Alternatively 
they were grown for 30 h, dechorionated and examined 
using a Zeiss Axiovert microscope equipped with differ- 
ential interference contrast and recorded with a Sony op- 
tical memory disc recorder. 
4.3. Whole mount in situ hybridization ana’ 
immunohistochemistry 
Whole mount in situ hybridizations were carried out as 
described previously by Joore et al. (1994). The axial 
probe used has been described by Str&le et al. (1993), 
the goosecoid antisense probe was made from a sub- 
cloned 252 bp RsaI fragment (bp 261-513) of the full- 
length cDNA cloned in pBSK-, linearized with EcoRI 
and synthesized with T3 RNA polymerase. For the no tail 
probe a PCR reaction was performed on the full-length 
cDNA (kindly provided by Dr Schulte-Merker) to obtain 
a fragment from bp 343 to 534 which was subcloned in 
pBSK-. After linearization of the plasmid with XbaI the 
RNA probe was synthesized with T7 RNA polymerase. 
For immunostaining, embryos were fixed overnight at 
4°C in 4% paraformaldehyde in PBS. After fixation em- 
bryos were rinsed with PBS, transferred to 100% metha- 
nol and stored at -20°C until use. Embryos were than 
gradually rehydrated from absolute methanol to PBS and 
rinsed with PBST (PBS, 0.1% Tween 20), incubated for 
30 min at room temperature in acetone, transferred to 
0.2 mM CaCl* for 5 min, again rinsed with PBST and 
incubated for 1 h in the blocking solution (PBST, 2% 
BSA). Incubation with the first antibodies was at 4°C 
overnight. Embryos were washed three times for 2 h each 
at room temperature in blocking solution and incubated 
overnight at 4°C with goat anti-mouse antibody coupled 
to FITC (Tago Inc.) or Cy3 (Jackson Laboratories). Em- 
bryos were washed in PBST, dehydrated through a graded 
series of methanol, cleared in Murray’s (l/3 benzylalco- 
ho1 and 213 benzylbenzoate) and analyzed by confocal 
laser scanning microscopy. 
4.4. RNase protection assay 
RNase protection analysis of goosecoid and no tail ex- 
pression was carried out as described previously (&tile 
et al., 1993). The 32P probes were synthesized from the 
same constructs as applied in the in situ hybridization 
experiments. RNA was isolated from 10 injected embryos 
fixed at 80-90% epiboly in Trizol (GIBCO-BRL). 
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